Call Us08045477330
Mesalazine Prolonged-release Tablets 1.2gms

Mesalazine Prolonged-release Tablets 1.2gms

Product Details:

  • Indication For the treatment and maintenance of remission of ulcerative colitis and Crohns disease
  • Dosage Form Prolonged-release Tablets
  • Salt Composition Mesalazine 1.2g
  • Feature Prolonged release formulation for extended action
  • Ingredients Mesalazine, excipients
  • Application Oral use to reduce inflammation in the colon
  • Physical Color/Texture White to off-white, oblong, film-coated tablets
  • Click to View more
X

Mesalazine Prolonged-release Tablets 1.2gms Price And Quantity

  • 200 INR
  • 1 Unit
  • Prescription only medicine
  • 10 tablets per blister pack
  • Pharmaceutical / Prescription medication
  • Oblong
  • Use with caution in patients with renal impairment
  • Dry place, below 25°C
  • Known hypersensitivity to mesalazine or salicylates
  • Controlled, prolonged release
  • Oral
  • 1.2g per tablet
  • As per regulatory submission

Mesalazine Prolonged-release Tablets 1.2gms Product Specifications

  • Mesalazine, excipients
  • 24 months
  • For the treatment and maintenance of remission of ulcerative colitis and Crohns disease
  • Store below 25C, protect from moisture and light
  • Mesalazine 1.2g
  • Oral use to reduce inflammation in the colon
  • Prolonged-release Tablets
  • White to off-white, oblong, film-coated tablets
  • Prolonged release formulation for extended action
  • Prescription only medicine
  • 10 tablets per blister pack
  • Pharmaceutical / Prescription medication
  • Oblong
  • Use with caution in patients with renal impairment
  • Dry place, below 25°C
  • Known hypersensitivity to mesalazine or salicylates
  • Controlled, prolonged release
  • Oral
  • 1.2g per tablet
  • As per regulatory submission

Mesalazine Prolonged-release Tablets 1.2gms Trade Information

  • 1 Days
  • 1 STRIP*10 TABLETS
  • All India
  • GMP

Product Description

The offered Mesalazine Prolonged-release Tablets 1.2gms are gastro-resistant, prolonged release tablets. It contains the active ingredient mesalazine. This medication is used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhoea, rectal bleeding, and stomach pain. The offered tablets are very effective and made for use by adults. The Mesalazine Prolonged-release Tablets 1.2gms are safe for use and made for use in various medical industries and commercial purposes.


Prolonged-Release Benefit

The Mesalazine prolonged-release formulation ensures a sustained release of the active ingredient, delivering therapeutic effects over an extended period. This promotes consistent management of inflammation associated with ulcerative colitis and Crohns disease. Prolonged release reduces the frequency of dosing and helps maintain stable drug levels, offering convenience and improved adherence for individuals requiring ongoing treatment.


Proper Storage Recommendations

To preserve the effectiveness of Mesalazine Prolonged-release Tablets 1.2g, store them below 25C in a dry environment, away from moisture and light. Following these precautions ensures the medication maintains its stability throughout its 24-month shelf life. This is essential for guaranteeing therapeutic reliability and patient safety over the course of treatment.

FAQs of Mesalazine Prolonged-release Tablets 1.2gms:


Q: How should Mesalazine Prolonged-release Tablets 1.2g be taken?

A: These tablets are administered orally and should be swallowed whole without crushing or chewing, allowing the controlled, prolonged-release mechanism to work effectively. Follow the dosing schedule as prescribed by your healthcare provider.

Q: What conditions are these tablets indicated for?

A: Mesalazine Prolonged-release Tablets 1.2g are indicated for both the treatment and maintenance of remission in ulcerative colitis and Crohns disease, helping to reduce inflammation in the colon.

Q: When should I store Mesalazine tablets under special conditions?

A: It is essential to store these tablets below 25C, in a dry area, protected from moisture and light at all times, to preserve their efficacy throughout the shelf life.

Q: Where can I obtain Mesalazine Prolonged-release Tablets 1.2g?

A: This medication is classified as prescription-only and can be obtained from licensed pharmacies, distributors, or hospitals in India, following a doctors prescription and valid registration as per regulatory submission.

Q: What benefits does the prolonged-release formulation offer?

A: The prolonged-release mechanism ensures a steady and extended release of mesalazine, providing ongoing inflammation control and potentially reducing the frequency of dosing compared to immediate-release formulations.

Q: Who should avoid taking Mesalazine Prolonged-release Tablets 1.2g?

A: Patients who have known hypersensitivity to mesalazine or other salicylates should not use this product. Use with caution in individuals with renal impairment; consult your physician for assessment and monitoring.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Capsules' category